Hundreds of millions of people are turning to chatbots to help figure out what's wrong with them. Doctors say that's not always a bad thing. In fact, many are using it themselves.

Prioritizing nonpharmacologic strategies, enhancing staff training, and distinguishing Delirium Superimposed on Dementia (DSD) are vital to improving outcomes for hospitalized patients with Alzheimer ...

A theatre company is using drama training to help doctors deal with challenging patients. Hull Truck Theatre's classes feature actors performing difficult GP consultations, with GPs giving feedback ...

Personality disorders, depression, anxiety, and chronic pain were patient characteristics that increased difficulty (relative risks, 2.2, 1.9, 2.1, and 1.9, respectively). HealthDay News — Providers ...

Everybody has bad days. At some point, you’ll encounter a difficult customer who believes that your business is to blame for their bad day. What happens next depends on how your team handles the ...

A systematic review of 45 studies found that physicians perceive one in six patient visits in non-psychiatric clinics as "difficult," and these encounters are more likely to involve patients with ...

PHOENIX, Arizona — For nursing students, delivering a life-altering diagnosis or navigating end-of-life discussions can be more daunting than any clinical procedure. At Creighton University’s Health ...

(RTTNews) - Drug major Johnson & Johnson has announced an agreement with the Trump Administration to lower drug prices, enabling millions of Americans to access medicines at significantly discounted ...

Tough talk can be, well, tough. But it’s also critical for ensuring your team is working at its best. Learn what holds managers back and how to remove the block that may be hurting your bottom line.

The HBR Executive Playbook on protecting governance, repairing trust, and keeping the work on track. by Rachel DuRose The job of a corporate board is to scrutinize management’s assumptions, ...

CHICAGO and FORT WORTH, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

PORTLAND, Ore., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced that the first patient has been enrolled in its new Phase 2b ...